NMIMC
GYRE icon

Northwestern Mutual Investment Management Company’s Gyre Therapeutics GYRE Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-205
Closed -$28K – 906
2016
Q3 		$28K Hold
205
– – ﹤0.01% 900
2016
Q2 		$35K Hold
205
– – ﹤0.01% 909
2016
Q1 		$39K Hold
205
– – ﹤0.01% 905
2015
Q4 		$72K Buy
+205
New +$80.6K ﹤0.01% 784

Other funds holding GYRE

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
CCM
Colorado Capital Management Boulder, Colorado $293M AUM 22.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Northwestern Mutual Investment Management Company's GYRE Position: Q4 2016 in Review

Northwestern Mutual Investment Management Company sold out of Gyre Therapeutics (GYRE) in Q4 2016, closing a stake of 205 shares — an estimated $28K sold.

Northwestern Mutual Investment Management Company first reported a position in GYRE in Q4 2015 and held it in 4 quarters. The position peaked at $72K in Q4 2015. 27 funds tracked by Wall St. Rank hold GYRE as of Q4 2016.

  • Northwestern Mutual Investment Management Company reported no remaining Gyre Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Northwestern Mutual Investment Management Company sold 205 Gyre Therapeutics shares in Q4 2016, an estimated $28K.
  • Northwestern Mutual Investment Management Company first reported a position in Gyre Therapeutics in Q4 2015 and held it in 4 quarters.
  • Northwestern Mutual Investment Management Company's Gyre Therapeutics position peaked at $72K in Q4 2015.
  • 27 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q4 2016.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q4 2016, filed 14 Feb 2017.